PEStore

Buyout PE

Imperial Capital Limited

Imperial Capital Limited acquires controlling stakes in established, profitable businesses, from Toronto, Canada. It states a focus on healthcare & life sciences, business & professional services and consumer & retail.

Capital raised$194macross 5 SEC-filed vehicles
Most recent fund2023filing since 2012
HeadquartersToronto, Canada
Stated cheque sizeEBITDA $0-30M

Stated investment criteria

What Imperial Capital Limited says it buys

Read from Imperial Capital Limited’s own website in August 2026. This is what the firm says it buys, not what anyone has recorded it buying, and figures are shown in the currency the firm itself used - nothing here is converted. Every line links to the page it was read from.

Maximum EBITDA it states$30m1
Transaction typesPlatform, Add-on, Buy-and-build1

A stated mandate is a firm’s description of itself and was true of the page on the day it was read; firms widen and narrow what they will look at without updating the site. Nothing here is a commitment by Imperial Capital Limited to consider any particular business, and nothing on this page is represented as being for sale.

SEC filings

What Imperial Capital Limited has raised

From this firm's own Form D filings. A fund files one within fifteen days of its first sale, under penalty of perjury, which makes these the hardest numbers on the page.

Vehicles filed5
Total capital raised$194m
Largest single vehicle$147m
Filing history2012 to 2023
Smallest accepted commitment$300k
Filed fromONTARIO, CANADA

Form D covers US-domiciled vehicles raised from accredited investors. It will not capture a fund raised outside the United States, separately managed accounts, or capital deployed off balance sheet, so treat these as a floor rather than a total.

Regulatory record

How Imperial Capital Limited is registered

From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.

Adviser statusExempt reporting adviser
Regulatory assets under managementNot reported by an ERA
Private funds advised7 · $1.5bn gross
SEC adviser numberCRD 316569

An exempt reporting adviser is not required to report regulatory assets under management, so the blank above means the question was not asked rather than that the answer is unknown. Where a figure exists it is the gross asset value of the private funds the firm advises, which is a different and usually larger measure.

Recorded transactions

Buying and selling

Deals in which Imperial Capital Limited is named as buyer or seller in the transaction archive. 1 recorded exit, most recently in 2016.

CompanySideCounterpartyYearConsideration
Lise Watier CosmétiquesSoldGroupe Marcelle2016$14m

Compiled from a transaction archive of 10,204 recorded deals. Most private transactions are never disclosed, so this is a sample of a firm’s activity rather than a complete record of it.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Imperial Capital Limited?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other buyout pe investors active in healthcare & life sciences.